Literature DB >> 2138337

Nootropic effects of ACE inhibitors in mice.

C Mondadori1, P Etienne.   

Abstract

The angiotensin converting enzyme (ACE) inhibitors captopril and enalapril and the nootropic piracetam reduced the amnesiogenic effects of cerebral electroshock treatment in mice. These compounds also directly improved passive-avoidance learning if administered before the learning trial. When given immediately after the learning trial, captopril and piracetam were active, but not enalapril. Captopril, but neither enalapril nor piracetam, facilitated memory retrieval after a 2-month retention interval. Unlike those of piracetam, the memory-improving effects of captopril and enalapril are not established by aldosterone-receptor blockade, suggesting that the two types of drug act via different mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138337     DOI: 10.1007/bf02244597

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Co-identity of brain angiotensin converting enzyme with a membrane bound dipeptidyl carboxypeptidase inactivating Met - enkephalin.

Authors:  M Benuck; N Marks
Journal:  Biochem Biophys Res Commun       Date:  1979-05-14       Impact factor: 3.575

2.  Cortisol secretion during intrapituitary infusion of angiotensin II in conscious dogs.

Authors:  J W Maran; F E Yates
Journal:  Am J Physiol       Date:  1977-10

3.  Captopril treatment of depression.

Authors:  R F Deicken
Journal:  Biol Psychiatry       Date:  1986-12       Impact factor: 13.382

4.  Enkephalin metabolism in brain and its inhibition.

Authors:  J C Schwartz; S De La Baume; C C Yi; P Chaillet; H Marcais-Collado; J Costentin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1982       Impact factor: 5.067

5.  Central effects of converting enzyme inhibitors.

Authors:  B A Schölkens; J Z Xiang; T Unger
Journal:  Clin Exp Hypertens A       Date:  1983

6.  Effect of captopril on proteins and peptide hormones.

Authors:  R P Igic; J T Gafford; E G Erdos
Journal:  Biochem Pharmacol       Date:  1981-03-15       Impact factor: 5.858

7.  Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase.

Authors:  E G Erdös; A R Johnson; N T Boyden
Journal:  Biochem Pharmacol       Date:  1978-03-01       Impact factor: 5.858

8.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

9.  Work performance, absenteeism and antihypertensive medications.

Authors:  S H Croog; A Sudilovsky; S Levine; M A Testa
Journal:  J Hypertens Suppl       Date:  1987-02

10.  Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas.

Authors:  A Arregui; E K Perry; M Rossor; B E Tomlinson
Journal:  J Neurochem       Date:  1982-05       Impact factor: 5.372

View more
  9 in total

1.  Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37,849, and strychnine in mice.

Authors:  C Mondadori; C Gentsch; B Hengerer; T Ducret; J Borkowski; A Racine; R Lederer; A Haeusler
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Mnemogenic effects of injecting RA-octil, a CE-inhibitor derivate, systemically or into the basal forebrain.

Authors:  P Gerhardt; R U Hasenöhrl; F J Hock; J P Huston
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Delayed emergence of effects of memory-enhancing drugs: implications for the dynamics of long-term memory.

Authors:  C Mondadori; B Hengerer; T Ducret; J Borkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

Review 4.  Effect of antihypertensive agents on quality of life in the elderly.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 5.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

Review 6.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 7.  Angiotensin converting enzyme inhibitors as potential cognitive enhancing agents.

Authors:  A M Domeney
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

8.  The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.

Authors:  Ashley J Porter; Katharine Pillidge; Ewelina M Grabowska; S Clare Stanford
Journal:  Eur Neuropsychopharmacol       Date:  2015-02-07       Impact factor: 4.600

Review 9.  Cognitive remission: a novel objective for the treatment of major depression?

Authors:  Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2016-01-22       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.